Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PPIH Activators

PPIH Activators are a diverse group of chemical compounds that act through various cellular signaling pathways to enhance the activity of Peptidyl-prolyl isomerase H (PPIH). Forskolin, by increasing intracellular cAMP levels, indirectly elevates protein kinase A (PKA) activity, which can lead to the phosphorylation of proteins associated with PPIH, potentially enhancing its isomerase activity. Similarly, Rolipram elevates cAMP levels by inhibiting phosphodiesterase 4, thereby activating PKA and influencing proteins that modulate PPIH activity. Epigallocatechin gallate, through inhibition of protein kinase C, could reduce the phosphorylation of inhibitory proteins, thus fostering a cellular environment more conducive to PPIH activity.

Ionomycin and Thapsigargin alter intracellular calcium levels, which can affect calmodulin, a calcium-binding messenger protein that might interact with and enhance PPIH activity. Okadaic acid and Calyculin A, as inhibitors of protein phosphatases, create a hyperphosphorylated state that could indirectly enhance PPIH's role in protein folding and function. KN-93 inhibits CaMKII, potentially increasing the availability of calmodulin to interact with PPIH. Anisomycin activates JNK signaling, which could create a phosphorylation pattern favorable to PPIH's activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin directly stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP can enhance PKA activity, which then phosphorylates serine/threonine residues on target proteins, potentially enhancing PPIH's peptidyl-prolyl isomerase activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels. The subsequent activation of PKA may increase the phosphorylation of proteins that interact with PPIH, enhancing its activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG inhibits protein kinase C, which could prevent the phosphorylation of inhibitor proteins, thereby reducing their suppression of PPIH activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels, which can modulate calmodulin activity. Activated calmodulin may then interact with and enhance the activity of PPIH.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 is a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Inhibition of CaMKII can increase the availability of calmodulin to bind and potentially enhance PPIH activity.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is a JNK activator that can enhance the phosphorylation of substrates involved in signaling pathways, potentially creating a more favorable environment for PPIH's activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), elevating cytosolic calcium levels, which could activate calmodulin and indirectly enhance PPIH activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is a calcium ionophore that raises intracellular calcium concentrations, potentially affecting calmodulin and thereby enhancing PPIH activity.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A binds to cyclophilins, a class of proteins that PPIH belongs to, potentially altering its conformation and enhancing its peptidyl-prolyl isomerase activity.